The MOBY Study: Efficacy of Birth Mobility
Launched by VIBWIFE AG · Jun 26, 2025
Trial Information
Current as of July 12, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called the MOBY Study, is looking at how moving around during labor affects the birth experience and outcomes for first-time mothers. The researchers want to find out if using a special system that encourages mobility during labor can help lower the chances of needing a cesarean section (C-section). They will also check how labor progresses, the use of pain medication, the health of the newborn, and how satisfied mothers feel about their birth experience.
Women who are at least 18 years old, expecting their first baby, carrying one baby in the head-down position, and who speak German or English may be eligible to join. Participants need to have a low-risk pregnancy and be ready to deliver after 37 weeks. During the study, mothers will receive either the usual care or care that includes the birth mobility system, and routine information about their labor and delivery will be collected. After birth, they will be asked to complete a short questionnaire about their experience. It’s important to know that this study is not yet recruiting participants, and women with certain health conditions or pregnancy complications won’t be able to join.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • German- or English-speaking
- • Able to provide written informed consent with capacity of judgment
- • Low-risk singleton pregnancy
- • Primiparous woman
- • Cephalic presentation
- • Gestational age at delivery ≥ 37 + 0 weeks
- Exclusion Criteria:
- • Multiparous woman
- • Not capable of understanding instructions for use of the mobility system (intervention group)
- • Scheduled (elective) cesarean section
- • Contraindication to vaginal delivery
- • Multiple pregnancy
- • Breech presentation
- • Estimated fetal weight \< 10th percentile or \> 90th percentile
- • Relevant fetal congenital abnormalities affecting neonatal adaptation
- • Pre-existing medical conditions significantly affecting mobility (e.g., orthopedic conditions, osteoporosis, multiple sclerosis, spinal cord injury)
- • Relevant intrapartum bleeding
- • Preeclampsia or HELLP syndrome
About Vibwife Ag
Vibwife AG is a clinical research organization dedicated to advancing medical innovation through the development and management of high-quality clinical trials. Committed to scientific excellence and patient safety, Vibwife AG collaborates closely with healthcare professionals, academic institutions, and industry partners to facilitate the efficient evaluation of new therapies and medical devices. Their expertise spans a range of therapeutic areas, emphasizing rigorous study design, regulatory compliance, and data integrity to support the successful translation of research into improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baden, Aargau, Switzerland
Patients applied
Trial Officials
Prof. Dr. med. Leonhard Schäffer
Principal Investigator
Kantonsspital Baden
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported